01 1Biovet Joint Stock Company
01 1Salinomycin
01 1Blank
NDC Package Code : 11311-889
Start Marketing Date : 2020-01-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.02kg/.02kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
81
PharmaCompass offers a list of Salinomycin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Salinomycin manufacturer or Salinomycin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Salinomycin manufacturer or Salinomycin supplier.
PharmaCompass also assists you with knowing the Salinomycin API Price utilized in the formulation of products. Salinomycin API Price is not always fixed or binding as the Salinomycin Price is obtained through a variety of data sources. The Salinomycin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Salinomycin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Salinomycin, including repackagers and relabelers. The FDA regulates Salinomycin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Salinomycin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Salinomycin supplier is an individual or a company that provides Salinomycin active pharmaceutical ingredient (API) or Salinomycin finished formulations upon request. The Salinomycin suppliers may include Salinomycin API manufacturers, exporters, distributors and traders.
click here to find a list of Salinomycin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Salinomycin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Salinomycin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Salinomycin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Salinomycin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Salinomycin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Salinomycin suppliers with NDC on PharmaCompass.
